Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Yang B, Ren G, Song E, et al. Current status and factors influencing surgical options for breast cancer in China: a nationwide Cross-Sectional survey of 110 hospitals. Oncologist. 2020;25(10):e1473–e80.
   PubMed Web of Science ®Google Scholar
• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.
   PubMed Web of Science ®Google Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346.
   PubMed Web of Science ®Google Scholar
• Wang H, Feng L, Zheng Y, et al. LINC00680 promotes the progression of non-small cell lung cancer and functions as a sponge of miR-410-3p to enhance HMGB1 expression. Onco Targets Ther. 2020;13:8183–8196.
   PubMed Web of Science ®Google Scholar
• Xiong X, Feng Y, Li L, et al. Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4. Oncol Rep. 2020;43:1503–1515.
   PubMed Web of Science ®Google Scholar
• Han L, Yan Y, Zhao L, et al. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway. J Cell Mol Med. 2020;24(11):6242–6252.
   PubMed Web of Science ®Google Scholar
• Feng L, Li J, Li F, et al. Long noncoding RNA VCAN-AS1 contributes to the progression of gastric cancer via regulating p53 expression. J Cell Physiol. 2020;235(5):4388–4398.
   PubMed Web of Science ®Google Scholar
• Wang J, Ding Y, Wu Y, et al. Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network. J Cell Biochem. 2020;121(1):876–887.
   PubMed Web of Science ®Google Scholar
• Kabekkodu SP, Shukla V, Varghese VK, et al.. Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018;93:1955–1986.
   PubMed Web of Science ®Google Scholar
• Xie F, Zhang L, Yao Q, et al. TUG1 promoted tumor progression by sponging miR-335-5p and regulating CXCR4-mediated infiltration of Pro-Tumor immunocytes in CTNNB1-Mutated hepatoblastoma. Onco Targets Ther. 2020;13:3105–3115.
   PubMed Web of Science ®Google Scholar
• McGuire A, Brown JA, Kerin MJ. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev. 2015;34(1):145–155.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang W, Azhati B, et al. miR-106a-5p Functions as a tumor suppressor by targeting VEGFA in renal cell carcinoma. Dis Markers. 2020;2020:8837941.
   PubMed Web of Science ®Google Scholar
• Guo J, Dou D, Zhang T, et al. HOTAIR promotes cisplatin resistance of osteosarcoma cells by regulating cell proliferation, invasion, and apoptosis via miR-106a-5p/STAT3 axis. Cell Transplant. 2020;29:963689720948447.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang W, Ding J, et al. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling. Thorac Cancer. 2020;11(2):379–388.
   PubMed Web of Science ®Google Scholar
• Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: a review. Int J Cancer. 2016;138(11):2570–2578.
   PubMed Web of Science ®Google Scholar
• Hajizadeh F, Okoye I, Esmaily M, et al. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019;237:116952.
   PubMed Web of Science ®Google Scholar
• Höckel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol. 2001;28:36–41.
   PubMed Web of Science ®Google Scholar
• Schumacker PT. Hypoxia-Inducible Factor-1 (HIF-1). Crit Care Med. 2005;33(Suppl):423–425.
   Google Scholar
• Xu Q, Briggs J, Park S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 2005;24(36):5552–5560.
   PubMed Web of Science ®Google Scholar
• Pawlus MR, Wang L, Hu CJ. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 2014;33(13):1670–1679.
   PubMed Web of Science ®Google Scholar
• Dong L, Cao X, Luo Y, et al. A positive feedback loop of lncRNA DSCR8/miR-98-5p/STAT3/HIF-1α plays a role in the progression of ovarian cancer. Front Oncol. 2020;10:1713.
   PubMed Web of Science ®Google Scholar
• Li G, Du P, He J, et al. CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression. Biochem Biophys Res Commun. 2021;556:1–8.
   PubMed Web of Science ®Google Scholar
• Cao C, Zhao G, Yu W, et al. Activation of STAT3 stimulates AHSP expression in K562 cells. Sci China Life Sci. 2014;57(5):488–494.
   PubMed Web of Science ®Google Scholar
• Li SC, Lee CC, Hsu CM, et al. IL-6 induces haptoglobin expression through activating STAT3 in human head and neck cancer. J Oral Pathol Med. 2020;49(1):49–54.
   PubMed Web of Science ®Google Scholar
• Cardoso F, Fallowfield L, Costa A, et al. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):vi25–30.
   PubMed Web of Science ®Google Scholar
• Kolak A, Kamińska M, Sygit K, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549–553.
   PubMed Web of Science ®Google Scholar
• Bill R, Christofori G. The relevance of EMT in breast cancer metastasis: correlation or causality? FEBS Lett. 2015;589(14):1577–1587.
   PubMed Web of Science ®Google Scholar
• Yang S, Sun S, Xu W, et al. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway. Mol Med Rep. 2020;21:1819–1832.
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang B, Zhang Y, et al. A long non-coding RNA OLBC15 promotes triple-negative breast cancer progression via enhancing ZNF326 degradation. J Clin Lab Anal. 2020;34(8):e23304.
   PubMed Web of Science ®Google Scholar
• Lv P, Qiu X, Gu Y, et al. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer. Biomed Pharmacother. 2019;110:294–301.
   PubMed Web of Science ®Google Scholar
• Değerli E, Torun V, Cansaran-Duman D. miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2. Biol Res. 2020;53(1):19.
   PubMed Web of Science ®Google Scholar
• Lei B, Wang D, Zhang M, et al. miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis. J Exp Clin Cancer Res. 2020;39(1):71.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Wang J, Wang T, et al. Combination of baicalein and miR-106a-5p mimics significantly alleviates IL-1β-induced inflammatory injury in CHON-001 cells. Exp Ther Med. 2021;21(4):345.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen Z, Pei L, et al. MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway. Bioengineered. 2021;12(1):2203–2213.
   PubMed Web of Science ®Google Scholar
• Li D, Wang Z, Chen Z, et al. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein. Biochem Biophys Res Commun. 2016;481(3–4):245–250.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Wang H, et al. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2. Int J Clin Exp Pathol. 2018;11:5622–5634.
   PubMed Web of Science ®Google Scholar
• Chao H, Zhang M, Hou H, et al. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p. Life Sci. 2020;243:117296.
   PubMed Web of Science ®Google Scholar
• Pan YJ, Wei LL, Wu XJ, et al. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death Dis. 2017;8(10):e3155.
   PubMedGoogle Scholar
• Zheng YJ, Zhao JY, Liang TS, et al. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma. Faseb J. 2019;33(11):12915–12928.
   PubMed Web of Science ®Google Scholar
• Xing L, Tang X, Wu K, et al. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p. Aging (Albany NY). 2020;13(1):424–436.
   PubMedGoogle Scholar
• Li M, Zhou Y, Xia T, et al. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Breast Cancer Res Treat. 2018;170(2):257–270.
   PubMed Web of Science ®Google Scholar
• Li JP, Xiang Y, Fan LJ, et al. Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer. J Cell Biochem. 2019;120(3):3137–3148.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ge Z, Wang Z, et al. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging (Albany NY). 2021;13(6):8115–8126.
   PubMedGoogle Scholar
• Wu M, Song D, Li H, et al. Negative regulators of STAT3 signaling pathway in cancers. Cancer Manag Res. 2019;11:4957–4969.
   PubMed Web of Science ®Google Scholar
• Wang T, Fahrmann JF, Lee H, et al. JAK/STAT3-Regulated fatty acid β-Oxidation is critical for breast cancer stem cell self-Renewal and chemoresistance. Cell Metab. 2018;27(1):136–50.e5.
   PubMed Web of Science ®Google Scholar
• Pang Y, Wu J, Li X, et al. NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression. Int J Oncol. 2019;55:745–754.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–732.
   PubMed Web of Science ®Google Scholar
• Zhao FL, Qin CF. EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3. Eur Rev Med Pharmacol Sci. 2019;23:1055–1062.
   PubMed Web of Science ®Google Scholar
• Aghazadeh S, Yazdanparast R. Activation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTEN. Biochim Biophys Acta Gen Subj. 2017;1861(8):1970–1980.
   PubMed Web of Science ®Google Scholar